CTOs on the Move

Acubalance Wellness Centre

www.acubalance.ca

 
Acubalance Wellness Centre is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.acubalance.ca
  • 828 8th Ave W Ste 250
    Vancouver, BC CAN V5Z 1E2
  • Phone: 604.678.8600

Executives

Name Title Contact Details

Similar Companies

MedVet Medical & Cancer Centers for Pets

MedVet Medical & Cancer Centers for Pets has 5 different locations: MedVet Columbus 300 E. Wilson Bridge Rd. Wothington, OH 43085 614-846-5800 800-891-9010 MedVet Cincinnati 3964 RedBank Rd. Fairfax, OH 45227 513-561-0069 877-841-5818 ...

Blue Zones

Longevity secrets from the worlds longest-lived people.

Specialty Media Inc

Specialty Media provides innovative products and services of the highest quality to the academic and industrial biological research community. Our products and services are designed with the needs of the bench researcher in mind. Specialty Media offers

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Heartland Health Region

Heartland Health Region is a Rosetown, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.